Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line
about
Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and preventionTrichomonas vaginalis exosomes deliver cargo to host cells and mediate host∶parasite interactionsThe Polycomb complex PRC2 and its mark in lifeInactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersComprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell linesCarcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.EZH2 couples pancreatic regeneration to neoplastic progression.The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancerEZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo.Histone modifiers in cancer: friends or foes?Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanismsDepletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formationA Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In VitroEpigenetic factors in cancer development: polycomb group proteins.Polycomb proteins in mammalian cell differentiation and plasticity.Epigenetic regulation of skin: focus on the Polycomb complexEpigenetic alterations in hematopoietic malignancies.Epigenetic regulation of epidermal differentiation.Epigenetic modifications in prostate cancer.A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.Recurring mutations in myeloproliferative neoplasms alter epigenetic regulation of gene expressionGlobal levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer.
P2860
Q26994739-DCD150F7-F299-4023-9799-36F6DA63A077Q28534629-CA71AE4C-731C-401C-ACEB-297E0EFD2B10Q29547358-21BE1745-9C55-4C3B-BBAC-1D3695C559DCQ29614510-8294154D-1E8B-4211-9A66-A58D83504355Q33766326-96A51B8B-666E-47F9-9564-42F1C42C04FBQ34024222-9ACB8CD7-8FA3-499F-BD24-7E2F7D0D9404Q34030984-7E4C18F3-F4FF-4048-B07A-2ADA1775C8EBQ34137728-151086E2-E462-4014-AE4C-F19E2DD572A2Q34197861-C4E62204-A8BA-40B2-BAAB-A539C426732FQ34541488-C9C4F040-9CA5-418B-A3A9-0D565583CF8BQ34569371-A2CB7368-7597-4B67-86D8-A4E501B1AF9CQ34786445-DA8675CF-70CB-4745-A93C-1B80B7450017Q35216079-DD73230D-7A22-400B-A0E0-993A3AE79066Q35640345-51729797-6032-44BC-AD71-33EE29AA06EDQ36070463-8B5FB29A-EDCD-44D4-BE37-66CB9EDBE7EEQ36394208-8225D240-6164-4A04-B84E-FE36D1B53883Q37822735-BC94558B-322B-4ADA-A66B-08084B028BB6Q37875927-8FD2846C-ED8E-4CA8-9AE6-A1C6F4BFC21FQ37982255-9C604B1F-2590-4911-8E71-DD473539A510Q38046794-F4625569-19DD-4861-8064-8B5A162342CAQ38184911-E770819D-205A-4A30-96C2-73B06057F5D1Q38261747-44C3FD15-4867-4304-975B-481EA3B9A8FAQ38723294-1E7F6CA1-FA3B-4B73-A920-0702016B55E2Q38740198-46A9FD34-E2F4-4C42-8989-B7BF04C32C2FQ39328341-E92EE085-D9E9-4AB1-91F7-8A005D8C9D0FQ48200477-21BCA4F4-4AF0-4166-98A9-61325D15B26D
P2860
Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polycomb group protein enhance ...... prostatic epithelial cell line
@en
Polycomb group protein enhance ...... rostatic epithelial cell line.
@nl
type
label
Polycomb group protein enhance ...... prostatic epithelial cell line
@en
Polycomb group protein enhance ...... rostatic epithelial cell line.
@nl
prefLabel
Polycomb group protein enhance ...... prostatic epithelial cell line
@en
Polycomb group protein enhance ...... rostatic epithelial cell line.
@nl
P2093
P2860
P1476
Polycomb group protein enhance ...... prostatic epithelial cell line
@en
P2093
Breanne D W Karanikolas
Marxa L Figueiredo
P2860
P304
P356
10.1158/1541-7786.MCR-09-0121
P577
2009-09-01T00:00:00Z